Innovating Works

NORMAGRUP TECHNOLOGY

Activa
RESERVIST: Repurposing manufacturing lines for providing medical and other products and services in case of spi... NORMAGRUP TECHNOLOGY participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 RESERVIST aims to establish ‘reservist cells’ that in times of crises can be activated within 48hrs to switch to manufacturing medical produ...
2020-10-30 - 2023-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.